The Impact of Multi-Touch Functional Digital Game on Intelligence and Vitality for the Community-dwelling Elderly
20. september 2022 oppdatert av: Samsung Medical Center
This single-blinded, randomized, controlled trial includes 32 elderly.
The participants were randomized to intervention(Happy Table) and control(cognitive stimulation activity) groups.
Each group is divided in 16 participants.
In one session, participants in the Happy Table group completed 40 minutes of intervention using Happy Table serious game, whereas those in the Control group completed 40 minutes of cognitive stimulation game.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
At the first visit, the subjects are fully informed of the study if appropriate after determining whether they meet the selection criteria.
This single-blinded, randomized, controlled trial includes 32 elderly.
The participants were randomized to intervention(Happy Table) and control(cognitive stimulation activity) groups.
Each group is divided in 16 participants.
In one session, participants in the Happy Table group completed 40 minutes of intervention using Happy Table serious game, whereas those in the Control group completed 40 minutes of cognitive stimulation game.
Studietype
Intervensjonell
Registrering (Faktiske)
32
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Seoul, Korea, Republikken, 06351
- Samsung Medical Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
65 år til 84 år (Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- community-dwelling senior citizens aged 65 to 84
- Those without a history of central nervous system(CNS) disease
Exclusion Criteria:
- When it is difficult to understand the task performance due to severe cognitive decline(Korean Simple Mental State Test, K-MMSE 10 points or less).
- When it is difficult to use this game device due to problems such as decreased vision or fracture of the upper limb
- In case of accompanying serious mental illness
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Functional digital game training group
These functional digital game programs have been developed to improve the intelligence and vitality in the community-dwelling elderly.
The program includes sub-categories such as attention, working memory, memory and executive functions with various levels of difficulty.
|
Functional digital game training group is divided in 16 participants.
In one session, participants in the functional digital game training group completed 40 minutes of intervention using various functional digital game such as working memory, memory, and attention.
(Total 10 session)
|
|
Eksperimentell: Individual cognitive training
Individual cognitive training has been used to improve the intelligence and cognitive function in community-dwelling elderly.
The program includes sub-categories such as attention, working memory, memory and executive functions with various levels of difficulty.
|
Functional digital game training group is divided in 16 participants.
In one session, participants in the individual cognitive training group completed 40 minutes of intervention using various cognitive training such as working memory, memory, and attention.
(Total 10 session)
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline performance on Stroop test (Neuropsychological test) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
It measures a participant's processing speed, selective attention and inhibitory control.
The participant will be asked to read 'word' of the colored words or 'name of the color' of the colored words in separate trials.
The main scores produced in this test are completion time and errors.
The contrast score of the two trial's completion time means interference.
|
Baseline, After the intervention (Day 13)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline performance on Fluency Test (Neuropsychological test) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
This is a generative naming test.
That measure how many words you can spontaneously speak within a limited time of words that fall into a specific category (e.g.
animals, store goods, vegetables) or words starting with a letter (e.g.
F • A • S or C·F·L).
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Trail Making Test (Neuropsychological test) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
It consists of type A and type B trials.
The participant should connect the numbers (1~25) as quickly as possible in Type A trial, and connect the numbers (1~13) and alphabets (A~L) alternatively as quickly as possible in type B trial.
The main scores produced in this test are completion time and errors.
Higher score means worse performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Digit Span Test (Neuropsychological test) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
It measures auditory attention span and includes forward and backward trials.
The participant listens to a series of numbers and calls the sequence correctly.
The sequence increases in each trial.
The final score is the longest number of sequential digits that the participant can remember correctly.
The scores range from 3 to 8. The higher the score, the better the performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline performance on Auditory Verbal Learning test (Neuropsychological test) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
It measures participant's verbal memory.
The participant will hear 15 words and recall them immediately and after 20 minutes again.
The main scores produced in this test are the numbers of recalled words of the immediate and delayed trials.
Immediate memory score is the sum of 5 trial's correct response and score ranges between 0 and 60.
Delayed memory score is the correct response of the delayed trial and the score range is 0 to 15.
Higher score means better performance.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on functional Near-Infrared Spectroscopy (fNIRS) during the intervention(Day 1 and 12)and after intervention completion(Day 12)
Tidsramme: Baseline, during the intervention(Day 1 and 12), Through intervention completion(Day 12)
|
It measures brain activity during cognitive tasks to see if cognitive training affects brain function.
|
Baseline, during the intervention(Day 1 and 12), Through intervention completion(Day 12)
|
|
Change from baseline activity on Contrasting Program/Go-No-Go test after the intervention (Day 13).
Tidsramme: Baseline, Day 13(After the intervention)
|
The Contrasting Program and go-no go test requires a subject to emit a simple motor response to one cue while inhibiting the response in the presence of another cue.
This test has been effective in demonstrating impulsivity (elevated commission error rate) in elderly with attention deficit.
|
Baseline, Day 13(After the intervention)
|
|
Change from baseline activity on Geriatric Depression Scale (GDS) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
GDS is a 15-item self-report assessment used to identify depression in the elderly.
A score of 0 to 5 is normal.
A score greater than 5 suggests depression
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on health-related quality of life instrument with 20 items (HINT-20) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
The total score of the HINT-20 is converted to a 0-100 scale, with higher scores indicating better health-related quality of life.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on General Self-Efficacy Scale (GSE) after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
General self-efficacy (GSE), individuals'belief in their ability to perform well in a variety of situations.
General self-efficacy (GSE) is the belief in one's competence to attempt difficult or novel tasks, and to cope with adversity arising from specific demanding situations.
|
Baseline, After the intervention (Day 13)
|
|
Change from baseline activity on International Physical Activity Questionnaire after the intervention (Day 13).
Tidsramme: Baseline, After the intervention (Day 13)
|
Physical Activity Questionnaire collects information on physical activity participation in three settings (or domains) as well as sedentary behaviour, comprising 16 questions.
|
Baseline, After the intervention (Day 13)
|
|
User Satisfaction Questionnaire after intervention.
Tidsramme: After the intervention (Day 13)
|
We evaluate the satisfaction questionnaire for each training.
|
After the intervention (Day 13)
|
|
Change from baseline activity on smart band activity through intervention completion(Day 12).
Tidsramme: Baseline, through intervention completion(Day 12)
|
Each participant was given an smart band(number of steps count) and instructed to wear it on the wrist during waking hours until completion of the training program.
This included both intervening training days (totaling 10).
|
Baseline, through intervention completion(Day 12)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
16. september 2021
Primær fullføring (Faktiske)
21. februar 2022
Studiet fullført (Faktiske)
4. august 2022
Datoer for studieregistrering
Først innsendt
5. april 2021
Først innsendt som oppfylte QC-kriteriene
4. mai 2021
Først lagt ut (Faktiske)
5. mai 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. september 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
20. september 2022
Sist bekreftet
1. april 2021
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2021-03-011
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .